Pharma Surge
Pharma Surge
Intelligence Layer
🇬🇧·May 6Research

[Articles] Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial

Publisher

L
Lancet Neurology

UK

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Lancet Neurology
Region
UK
Scope
Research
Published
May 6, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on thelancet.com

Leave the platform to read the original full article on the publisher site.

Source: Lancet Neurology

Scope: Research

Open original article
[Articles] Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial | Pharma Surge